Skip to main content
Erschienen in: Journal of Neurology 2/2017

20.12.2016 | Original Communication

Long-term risk of falls in an incident Parkinson’s disease cohort: the Norwegian ParkWest study

verfasst von: Ylva Hivand Hiorth, Guido Alves, Jan Petter Larsen, Jörn Schulz, Ole-Bjørn Tysnes, Kenn Freddy Pedersen

Erschienen in: Journal of Neurology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to examine the frequency, development, concomitants, and risk factors of falls in a population-based incident Parkinson’s disease (PD) cohort. One hundred eighty-one drug-naïve patients with incident PD and 173 normal controls recruited from the Norwegian ParkWest study were prospectively monitored over 7 years. Information on falls was obtained biannually from patients, and at baseline and after 1, 3, 5, and 7 years of follow-up in control subjects. Generalized estimating equation models for correlated data were applied to investigate concomitant features of falls and risk factors for incident falls during 7 years of follow-up in PD. Overall, 64.1% of patients reported falling during the study period. The 7-year cumulative incidence of falls in non-falling patients at baseline (n = 153) was 57.5%, with a relative risk to controls of at least 3.1 (95% confidence interval 1.5–6.3; p < 0.002). Significant concomitants of falls in patients during the study period were higher age, Unified PD Rating Scale motor score, postural instability and gait difficulties (PIGD) phenotype, dementia, and follow-up time. Higher age at baseline, PIGD phenotype at 1-year visit, and follow-up time were independent risk factors for incident falls during follow-up. Nearly two-thirds of patients in the general PD population experience falls within 7 years of diagnosis, representing a more than threefold increased risk compared to age- and gender-matched controls. Patients with higher age at baseline and early PIGD have the greatest risk of falling and may, therefore, be the prime target of specialized assessment and treatment interventions.
Literatur
2.
Zurück zum Zitat Hiorth YH, Larsen JP, Lode K, Tysnes OB, Godfrey A, Lord S, Rochester L, Pedersen KF (2016) Impact of falls on physical activity in people with Parkinson’s Disease. J Parkinson’s Dis 6(1):175–182. doi:10.3233/JPD-150640 CrossRef Hiorth YH, Larsen JP, Lode K, Tysnes OB, Godfrey A, Lord S, Rochester L, Pedersen KF (2016) Impact of falls on physical activity in people with Parkinson’s Disease. J Parkinson’s Dis 6(1):175–182. doi:10.​3233/​JPD-150640 CrossRef
4.
5.
Zurück zum Zitat Bach JP, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G (2011) Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord 26(12):2286–2290. doi:10.1002/mds.23878 CrossRefPubMed Bach JP, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G (2011) Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord 26(12):2286–2290. doi:10.​1002/​mds.​23878 CrossRefPubMed
8.
Zurück zum Zitat Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord 22(13):1892–1900. doi:10.1002/mds.21598 CrossRefPubMed Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord 22(13):1892–1900. doi:10.​1002/​mds.​21598 CrossRefPubMed
9.
Zurück zum Zitat Paul SS, Canning CG, Sherrington C, Lord SR, Close JC, Fung VS (2013) Three simple clinical tests to accurately predict falls in people with Parkinson’s disease. Mov Disord 28(5):655–662. doi:10.1002/mds.25404 CrossRefPubMed Paul SS, Canning CG, Sherrington C, Lord SR, Close JC, Fung VS (2013) Three simple clinical tests to accurately predict falls in people with Parkinson’s disease. Mov Disord 28(5):655–662. doi:10.​1002/​mds.​25404 CrossRefPubMed
10.
Zurück zum Zitat Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP, Norwegian ParkWest Study g (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80(8):851–857. doi:10.1136/jnnp.2008.168211 CrossRefPubMed Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP, Norwegian ParkWest Study g (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80(8):851–857. doi:10.​1136/​jnnp.​2008.​168211 CrossRefPubMed
12.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRefPubMedPubMedCentral Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Fahn S, Elton R, Program Members UPDRS (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan Healthcare Information, Florham Park Fahn S, Elton R, Program Members UPDRS (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan Healthcare Information, Florham Park
14.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442CrossRefPubMed Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442CrossRefPubMed
15.
Zurück zum Zitat Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40(10):1529–1534CrossRefPubMed Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40(10):1529–1534CrossRefPubMed
16.
Zurück zum Zitat Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6(3):165–170CrossRefPubMed Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6(3):165–170CrossRefPubMed
17.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed
18.
Zurück zum Zitat Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707. doi:10.1002/mds.21507 (quiz 1837) CrossRefPubMed Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707. doi:10.​1002/​mds.​21507 (quiz 1837) CrossRefPubMed
19.
Zurück zum Zitat Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatr 134:382–389CrossRef Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatr 134:382–389CrossRef
20.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653. doi:10.1002/mds.23429 CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653. doi:10.​1002/​mds.​23429 CrossRefPubMed
21.
Zurück zum Zitat Lamb SE, Jorstad-Stein EC, Hauer K, Becker C, Prevention of Falls Network E, Outcomes Consensus G (2005) Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 53(9):1618–1622. doi:10.1111/j.1532-5415.2005.53455.x CrossRefPubMed Lamb SE, Jorstad-Stein EC, Hauer K, Becker C, Prevention of Falls Network E, Outcomes Consensus G (2005) Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 53(9):1618–1622. doi:10.​1111/​j.​1532-5415.​2005.​53455.​x CrossRefPubMed
22.
Zurück zum Zitat Von Hippel P (2007) Regression with missing Ys: an improved strategy for analyzing multiply imputed data. Sociol Methodol 37:83–117CrossRef Von Hippel P (2007) Regression with missing Ys: an improved strategy for analyzing multiply imputed data. Sociol Methodol 37:83–117CrossRef
24.
Zurück zum Zitat Lord S, Galna B, Yarnall AJ, Coleman S, Burn D, Rochester L (2016) Predicting first fall in newly diagnosed Parkinson’s disease: insights from a fall-naive cohort. Mov Disord. doi:10.1002/mds.26742 Lord S, Galna B, Yarnall AJ, Coleman S, Burn D, Rochester L (2016) Predicting first fall in newly diagnosed Parkinson’s disease: insights from a fall-naive cohort. Mov Disord. doi:10.​1002/​mds.​26742
25.
Zurück zum Zitat Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. doi:10.1002/mds.26424 CrossRefPubMed Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. doi:10.​1002/​mds.​26424 CrossRefPubMed
27.
Zurück zum Zitat Hely MA, Morris JG, Reid WG, Trafficante R (2005) Sydney Multicenter Study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord 20(2):190–199. doi:10.1002/mds.20324 CrossRefPubMed Hely MA, Morris JG, Reid WG, Trafficante R (2005) Sydney Multicenter Study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord 20(2):190–199. doi:10.​1002/​mds.​20324 CrossRefPubMed
28.
Zurück zum Zitat Auyeung M, Tsoi TH, Mok V, Cheung CM, Lee CN, Li R, Yeung E (2012) Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. J Neurol Neurosurg Psychiatry 83(6):607–611. doi:10.1136/jnnp-2011-301590 CrossRefPubMed Auyeung M, Tsoi TH, Mok V, Cheung CM, Lee CN, Li R, Yeung E (2012) Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. J Neurol Neurosurg Psychiatry 83(6):607–611. doi:10.​1136/​jnnp-2011-301590 CrossRefPubMed
29.
Zurück zum Zitat Lord SR (2007) Falls in older people: risk factors and strategies for prevention, 2nd edn. Cambridge University Press, CambridgeCrossRef Lord SR (2007) Falls in older people: risk factors and strategies for prevention, 2nd edn. Cambridge University Press, CambridgeCrossRef
30.
Zurück zum Zitat Almeida LR, Valenca GT, Negreiros NN, Pinto EB, Oliveira-Filho J (2014) Recurrent falls in people with parkinson’s disease without cognitive impairment: focusing on modifiable risk factors. Parkinson’s Dis 2014:432924 Almeida LR, Valenca GT, Negreiros NN, Pinto EB, Oliveira-Filho J (2014) Recurrent falls in people with parkinson’s disease without cognitive impairment: focusing on modifiable risk factors. Parkinson’s Dis 2014:432924
35.
Zurück zum Zitat Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y (2016) Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 15(3):249–258. doi:10.1016/S1474-4422(15)00389-0 CrossRefPubMed Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y (2016) Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 15(3):249–258. doi:10.​1016/​S1474-4422(15)00389-0 CrossRefPubMed
Metadaten
Titel
Long-term risk of falls in an incident Parkinson’s disease cohort: the Norwegian ParkWest study
verfasst von
Ylva Hivand Hiorth
Guido Alves
Jan Petter Larsen
Jörn Schulz
Ole-Bjørn Tysnes
Kenn Freddy Pedersen
Publikationsdatum
20.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8365-z

Weitere Artikel der Ausgabe 2/2017

Journal of Neurology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.